Valneva’s success stems from the dedication and expertise of over 750 employees spanning the whole value chain, from R&D to commercialization.
In 2021, Valneva achieved several major milestones, further enhancing its unique value proposition.
Valneva aims to become a highly valued, internationally known vaccine company focusing on products that can make a difference in people’s lives.
Frédéric Jacotot General Counsel and Corporate Secretary
Our commitment to Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.
Valneva has defined long-term responsible business commitments, which reflect global health needs and sit across four key focus areas. Our four pillars are the foundation for our Corporate Social Responsibility approach.